- 专利标题： USE OF IGFBP7 FOR TREATING MALARIA
-
申请号： US17426756申请日： 2020-01-30
-
公开(公告)号： US20220096604A1公开(公告)日： 2022-03-31
- 发明人: Wenn-Chyau LEE , Laurent RENIA
- 申请人： AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
- 申请人地址： SG Singapore
- 专利权人： AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
- 当前专利权人： AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
- 当前专利权人地址： SG Singapore
- 优先权： SG10201900872X 20190130
- 国际申请： PCT/SG2020/050043 WO 20200130
- 主分类号： A61K38/36
- IPC分类号： A61K38/36 ; A61K38/18 ; A61K31/366 ; A61K31/357 ; A61K31/4706 ; A61K31/4709 ; A61K31/506 ; A61K31/635 ; A61K31/65 ; A61K31/137 ; A61K31/155 ; A61P33/06
摘要：
The invention relates to a composition comprising insulin growth factor binding protein 7 (IGFBP7) for treating malaria or reducing the phenomenon of IRB C-endothelial cytoadherence. The composition can further comprise Von Willebrand Factor (VWF) and/or thrombospondin-1 (TSP-1). The composition can also be used as an adjunct therapeutic agent alongside other anti-malarial drugs.
公开/授权文献
- US12109253B2 Use of IGFBP7 for treating malaria 公开/授权日：2024-10-08
信息查询
IPC分类:
